搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Pulmonaryhypertensionnews.com
2 天
Imaging technique may detect earliest signs of PAH tissue changes
An imaging technique called 18F-FAPI PET may be able to detect early signs of changes in blood vessel tissues in PAH, a new ...
Pulmonaryhypertensionnews.com
5 天
Adempas helps lower risk in PAH patients, newer risk model confirms
A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...
Pulmonaryhypertensionnews.com
10 天
Winrevair regimen balances efficacy, safety in PAH: Analysis
The dosing regimen for Winrevair is optimal for balancing safety and effectiveness in adults with PAH, according to clinical ...
Pulmonaryhypertensionnews.com
14 天
Weight-based Uptravi dosing appropriate for PAH children: Study
A body weight-adjusted regimen of Uptravi dosing for children and adolescents with PAH was deemed appropriate, according to a ...
Pulmonaryhypertensionnews.com
14 天
PH can impose physical restrictions, but don’t limit yourself
Living with PH, it's easy to focus on what we can't do instead of what we can. Columnist Colleen Steele's advice? Don't limit ...
Pulmonaryhypertensionnews.com
16 天
Phase 2 trial of tiprelestat for PAH receives FDA advice
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial hypertension, the company states.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈